赛托生物(300583.SZ)：子公司收到化学原料药欧洲CEP证书

Core Viewpoint - Saito Bio (300583.SZ) announced that its subsidiary, Shandong Sry Pharmaceutical Co., Ltd., has received the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines (EDQM) for its active pharmaceutical ingredient, fluticasone propionate [1] Group 1: Company Developments - The receipt of the CEP certificate is a significant milestone for Saito Bio, as it validates the quality of its fluticasone propionate product for use in Europe [1] - Fluticasone propionate is a potent glucocorticoid used in nasal sprays to treat seasonal and perennial allergic rhinitis for patients aged 2 years and older, and in inhalation powder for the treatment of asthma and chronic obstructive pulmonary disease (COPD) [1]